{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:39:09Z","timestamp":1760549949523,"version":"3.41.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Health, National Institute of Drug Abuse","award":["R01 DA022370"],"award-info":[{"award-number":["R01 DA022370"]}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["U54GM104942"],"award-info":[{"award-number":["U54GM104942"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ejphar.2016.02.031","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T07:46:53Z","timestamp":1455004013000},"page":"149-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABAA receptors"],"prefix":"10.1016","volume":"775","author":[{"given":"Manish","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn H.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.02.031_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1520\/JFS10259J","article-title":"Carisoprodol-related death in a child","volume":"20","author":"Adams","year":"1975","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.ejphar.2016.02.031_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0026-895X(24)12165-7","article-title":"A single hydrophobic residue confers barbiturate sensitivity to gamma-aminobutyric acid type C receptor","volume":"55","author":"Amin","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.02.031_bib3","first-page":"227","article-title":"Homomeric rho 1 GABA channels: activation properties and domains","volume":"2","author":"Amin","year":"1994","journal-title":"Recep. Chan."},{"key":"10.1016\/j.ejphar.2016.02.031_bib4","first-page":"403","article-title":"Symposium on anxiety and a decade of tranquilizer therapy. the tranquilizer decade","volume":"5","author":"Berger","year":"1964","journal-title":"J. Neuropsychiatr."},{"key":"10.1016\/j.ejphar.2016.02.031_bib5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1749-6632.1960.tb42792.x","article-title":"The history, chemistry, and pharmacology of carisoprodol","volume":"86","author":"Berger","year":"1960","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.ejphar.2016.02.031_bib6","doi-asserted-by":"crossref","first-page":"10934","DOI":"10.1523\/JNEUROSCI.23-34-10934.2003","article-title":"Neurosteroids shift partial agonist activation of GABA(A) receptor channels from low- to high-efficacy gating patterns","volume":"23","author":"Bianchi","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2016.02.031_bib7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1471-4159.1998.70030899.x","article-title":"Expression of GABA receptor rho subunits in rat brain","volume":"70","author":"Boue-Grabot","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2016.02.031_bib8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/clpt.2011.250","article-title":"Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential","volume":"91","author":"Bramness","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2016.02.031_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.drugalcdep.2004.01.007","article-title":"Impairment due to intake of carisoprodol","volume":"74","author":"Bramness","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2016.02.031_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuron.2011.12.012","article-title":"Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease","volume":"73","author":"Brickley","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2016.02.031_bib11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.bjp.0704795","article-title":"Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors","volume":"136","author":"Brown","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.02.031_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1124\/mol.112.078410","article-title":"Neurosteroid analog photolabeling of a site in the third transmembrane domain of the beta3 subunit of the GABA(A) receptor","volume":"82","author":"Chen","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.02.031_bib13","doi-asserted-by":"crossref","first-page":"19343","DOI":"10.1074\/jbc.M113.479725","article-title":"Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the Human alpha1beta3gamma2 gamma-aminobutyric acid Type A (GABAA) receptor","volume":"288","author":"Chiara","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2016.02.031_bib14","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors","volume":"99","author":"Crestani","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2016.02.031_bib15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/mol.59.3.442","article-title":"Molecular targets for the myorelaxant action of diazepam","volume":"59","author":"Crestani","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.02.031_bib16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.bjp.0700987","article-title":"Modulation by general anaesthetics of rat GABAA receptors comprised of alpha 1 beta 3 and beta 3 subunits expressed in human embryonic kidney 293 cells","volume":"120","author":"Davies","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.02.031_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-3565(25)26382-0","article-title":"The metabolic fate of carisoprodol in dog","volume":"138","author":"Douglas","year":"1962","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.02.031_bib18","first-page":"1223","article-title":"Abuse of skeletal muscle relaxants","volume":"44","author":"Elder","year":"1991","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ejphar.2016.02.031_bib19","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1460-9568.1995.tb01144.x","article-title":"Expression of GABA receptor rho 1 and rho 2 subunits in the retina and brain of the rat","volume":"7","author":"Enz","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2016.02.031_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM195707112570207","article-title":"Addiction to meprobamate","volume":"257","author":"Ewing","year":"1957","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2016.02.031_bib21","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1124\/mol.104.002543","article-title":"Pentobarbital differentially modulates alpha1beta3delta and alpha1beta3gamma2L GABAA receptor currents","volume":"66","author":"Feng","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.02.031_bib22","first-page":"180","article-title":"Abuse potential of soma: the GABA(A) receptor as a target","volume":"1","author":"Gonzalez","year":"2009","journal-title":"Mol. Cell. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.02.031_bib23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.109.151142","article-title":"Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies","volume":"329","author":"Gonzalez","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.02.031_bib24","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1056\/NEJM197412052912308","article-title":"Drug therapy. benzodiazepines (second of two parts)","volume":"291","author":"Greenblatt","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2016.02.031_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1527-3458.2003.tb00241.x","article-title":"SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms","volume":"9","author":"Griebel","year":"2003","journal-title":"CNS Drug. Rev."},{"key":"10.1016\/j.ejphar.2016.02.031_bib26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1124\/mol.113.090985","article-title":"Identifying barbiturate binding sites in a nicotinic acetylcholine receptor with [3H]allyl m-trifluoromethyldiazirine mephobarbital, a photoreactive barbiturate","volume":"85","author":"Hamouda","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.02.031_bib27","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0026-895X(25)09083-2","article-title":"3 alpha-Hydroxy-3 beta-trifluoromethyl\u22125 alpha-pregnan\u221220-one (Co 2\u22121970): a partial agonist at the neuroactive steroid site of the gamma-aminobutyric acidA receptor","volume":"49","author":"Hawkinson","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.02.031_bib28","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3181\/00379727-87-21459","article-title":"Effect of 2-methyl, 2-n-propyl\u22121,3-propanediol dicarbamate (Miltown) on central nervous system","volume":"87","author":"Hendley","year":"1954","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2016.02.031_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000220338","article-title":"Kinetics of meprobamate elimination in humans","volume":"9","author":"Hollister","year":"1964","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ejphar.2016.02.031_bib30","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1476-5381.1993.tb12866.x","article-title":"The influence of the gamma2L subunit of the modulation of responses to GABAA receptor activation","volume":"108","author":"Horne","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.02.031_bib31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature05324","article-title":"Endogenous steroids regulate GABAA receptors through two distinct transmembrane sites","volume":"444","author":"Hosie","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2016.02.031_bib32","first-page":"37\/D27","article-title":"GABAA receptor subunit domains that confer carisoprodol sensitivity","volume":"319","author":"Kumar","year":"2013","journal-title":"Soc. Neurosci. Abst."},{"key":"10.1016\/j.ejphar.2016.02.031_bib33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neuropharm.2015.04.007","article-title":"Assessment of subunit-dependent direct gating and allosteric modulatory effects of carisoprodol at GABAA receptors","volume":"97","author":"Kumar","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2016.02.031_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pbb.2008.01.001","article-title":"Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond","volume":"90","author":"Licata","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2016.02.031_bib35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00007611-199307000-00006","article-title":"Carisoprodol (soma): a new and cautious perspective on an old agent","volume":"86","author":"Littrell","year":"1993","journal-title":"South MEd. J."},{"key":"10.1016\/j.ejphar.2016.02.031_bib36","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/jm00303a029","article-title":"Carbamate derivatives related to meprobamate","volume":"12","author":"Ludwig","year":"1969","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.02.031_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"Low","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2016.02.031_bib38","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jama.1967.03130130025006","article-title":"Meprobamate overdosage evaluation of its severity and methods of treatment","volume":"201","author":"Maddock","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2016.02.031_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1113\/expphysiol.1990.sp003394","article-title":"Actions of steroids and bemegride on the GABAA receptor of mouse spinal neurones in culture","volume":"75","author":"Mistry","year":"1990","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ejphar.2016.02.031_bib40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00007691-199408000-00001","article-title":"Carisoprodol elimination in humans","volume":"16","author":"Olsen","year":"1994","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejphar.2016.02.031_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International union of pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2016.02.031_bib42","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/338582a0","article-title":"Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology","volume":"338","author":"Pritchett","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2016.02.031_bib43","first-page":"75","article-title":"Somatic dysfunction during carisoprodol cessation: evidence for a carisoprodol withdrawal syndrome","volume":"103","author":"Reeves","year":"2003","journal-title":"J. Am. Osteopath. Assoc."},{"key":"10.1016\/j.ejphar.2016.02.031_bib44","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0022-3565(24)36535-8","article-title":"Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate","volume":"280","author":"Rho","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.02.031_bib45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-pharmtox-011613-135947","article-title":"GABAA receptor subtypes: therapeutic potential in down syndrome, affective disorders, schizophrenia, and autism","volume":"54","author":"Rudolph","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2016.02.031_bib46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/archfami.2.4.429","article-title":"Carisoprodol as a drug of abuse","volume":"2","author":"Rust","year":"1993","journal-title":"Arch. Fam. Med."},{"key":"10.1016\/j.ejphar.2016.02.031_bib47","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0278-5846(84)80022-6","article-title":"Specific antagonism of the behavioral effects of chlordiazepoxide and pentobarbital in the rat","volume":"8","author":"Schechter","year":"1984","journal-title":"Prog. Neuropsychopharmacol. Biol. Psych."},{"key":"10.1016\/j.ejphar.2016.02.031_bib48","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/pds.3821","article-title":"What are we treating with opioid and sedative-hypnotic combination therapy?","volume":"24","author":"Sullivan","year":"2015","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ejphar.2016.02.031_bib49","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature08758","article-title":"Neural bases for addictive properties of benzodiazepines","volume":"463","author":"Tan","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2016.02.031_bib50","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.clinthera.2004.09.008","article-title":"Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine Hydrochloride, and metaxalone","volume":"26","author":"Toth","year":"2004","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2016.02.031_bib51","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1523\/JNEUROSCI.1067-04.2004","article-title":"Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice","volume":"24","author":"van Rijnsoever","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2016.02.031_bib52","doi-asserted-by":"crossref","first-page":"14187","DOI":"10.1074\/jbc.M110.104257","article-title":"Stoichiometry of expressed alpha(4)beta(2)delta gamma-aminobutyric acid Type A receptors depends on the ratio of subunit cDNA transfected","volume":"285","author":"Wagoner","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2016.02.031_bib53","first-page":"427","article-title":"Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain","volume":"39","author":"Witenko","year":"2014","journal-title":"P T"},{"key":"10.1016\/j.ejphar.2016.02.031_bib54","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1523\/JNEUROSCI.22-05-01541.2002","article-title":"Enhanced neurosteroid potentiation of ternary GABA(A) receptors containing the delta subunit","volume":"22","author":"Wohlfarth","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2016.02.031_bib55","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.pbb.2011.08.011","article-title":"Characterizing the subjective and psychomotor effects of carisoprodol in healthy volunteers","volume":"100","author":"Zacny","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2016.02.031_bib56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.drugalcdep.2011.07.006","article-title":"Subjective and psychomotor effects of carisoprodol in combination with oxycodone in healthy volunteers","volume":"120","author":"Zacny","year":"2012","journal-title":"Drug Alcohol Depend."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916300541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916300541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T10:07:27Z","timestamp":1748772447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916300541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":56,"alternative-id":["S0014299916300541"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.02.031","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABAA receptors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}